4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-22-000006
Chief Financial Officer sold 5,000 shares at $16.03 ($80,150)
From the SEC's structured data for this filing
Trades in this filing
Greenstein Leonard M. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-15 | Sale : show line 1 in the form | −5,000 | $16.03 | $80,150 | 59,289 | D |
| Open-market sales · 5,000 sh · avg $16.03 · $80,150 | ||||||
Loading xslF345X03/wf-form4_166336036117534.xml…